Discontinuation report TARO-TEMOZOLOMIDE
Report ID | 123258 |
Drug Identification Number | 02443511 |
Brand name | TARO-TEMOZOLOMIDE |
Common or Proper name | TEMOZOLOMIDE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TEMOZOLOMIDE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 20 |
ATC code | L01AX |
ATC description | ALKYLATINGAGENTS |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-07-31 |
Remaining supply date | 2020-07-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-08-28 | French | Compare |
v1 | 2020-08-28 | English | Compare |
Showing 1 to 2 of 2